Why the study?
What are the clinical and device-related predictors of a high defibrillation threshold during routine ICD implantation?
Population
864 patients undergoing a new pectoral implantable cardioverter defibrillator implantation between 2006 and…
Design
Cohort
Authors
Loading...
Suggests targeted DFT testing may be warranted in patients with severe LV dysfunction or right-sided implants.
What are the clinical and device-related predictors of a high defibrillation threshold during routine ICD implantation?
While routine DFT testing may not be necessary for all patients, it remains clinically important for high-risk subgroups, particularly those with LVEF ≤25% or right-sided pre-pectoral implantations.
Al-Atia et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: